Why don't fistulas mature?

Kidney International

Volumn 70, Issue 8, 2006, Pages 1413-1422

  Dixon, B S ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Arteriovenous fistula; Blood flow; Hemodialysis; Stenosis; Survival

Indexed keywords

ALAGEBRIUM; ARGININE; COLLAGEN; CYTOKINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; FURIN; GELATINASE; GELATINASE A; GELATINASE B; GELFOAM; INTERLEUKIN 1BETA; MESSENGER RNA; METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET DERIVED GROWTH FACTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSFORMING GROWTH FACTOR BETA;

ARTERIOVENOUS FISTULA; ARTERY DILATATION; ARTERY INTIMA PROLIFERATION; BLOOD FLOW; BLOOD VESSEL INJURY; CLINICAL TRIAL; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; PRESSURE GRADIENT; PRIORITY JOURNAL; REVIEW; SHEAR STRESS; THROMBOSIS; VASCULAR ACCESS; VEIN DILATATION;

ARTERIOVENOUS SHUNT, SURGICAL; HUMANS; REGIONAL BLOOD FLOW; RENAL DIALYSIS; TIME FACTORS; VASODILATION;

EID: 33749522902     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001747     Document Type: Review

References (103)

1. Gibson KD, Gillen DL, Caps MT et al. Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study. J Vasc Surg 2001; 34: 694-700.
2. Allon M, Robbin ML. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int 2002; 62: 1109-1124.
3. Konner K, Nonnast-Daniel B, Ritz E. The arteriovenous fistula. J Am Soc Nephrol 2003; 14: 1669-1680.
4. Asif A, Roy-Chaudhury P, Beathard GA. Early arteriovenous fistula failure: a logical proposal for when and how to intervene. Clin J Am Soc Nephrol 2006; 1: 332-339.
5. Roy-Chaudhury P, Sukhatme VP, Cheung AK. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol 2006; 17: 1112-1127.
6. Dixon BS, Novak L, Fangman J. Hemodialysis vascular access survival: upper-arm native arteriovenous fistula. Am J Kidney Dis 2002; 39: 92-101.
7. Beathard GA, Arnold P, Jackson J et al. Aggressive treatment of early fistula failure. Kidney Int 2003; 64: 1487-1494.
8. Dember LM, Kaufman JS, Beck GJ et al. Design of the dialysis access consortium (DAC) clopidogrel prevention of early AV fistula thrombosis. Trial Clin 2005; 2: 413-422.
9. Sivanesan S, How TV, Bakran A. Characterizing flow distributions in AV fistulae for haemodialysis access. Nephrol Dial Transplant 1998; 13: 3108-3110.
10. Duncan H, Ferguson L, Faris I. Incidence of the radial steal syndrome in patients with Brescia fistula for hemodialysis: its clinical significance. J Vasc Surg 1986; 4: 144-147.
11. Billet A, Queral LA, Polito WF et al. The vascular steal phenomenon: an experimental model. Surgery 1984; 96: 923-928.
12. Ramuzat A, How TV, Bakran A. Steal phenomenon in radiocephalic arteriovenous fistula. In vitro haemodynamic and electrical resistance simulation studies. Eur J Vasc Endovasc Surg 2003; 25: 246-253.
13. Joannides R, Bakkali EH, Le Roy F et al. Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis. Nephrol Dial Transplant 1997; 12: 2623-2628.
14. Wedgwood KR, Wiggins PA, Guillou PJ. A prospective study of end-to-side vs. side-to-side arteriovenous fistulas for haemodialysis. Br J Surg 1984; 71: 640-642.
15. Remuzzi A, Ene-Iordache B, Mosconi L et al. Radial artery wall shear stress evaluation in patients with arteriovenous fistula for hemodialysis access. Biorheology 2003; 40: 423-430.
16. Lomonte C, Casucci F, Antonelli M et al. Is there a place for duplex screening of the brachial artery in the maturation of arteriovenous fistulas? Semin Dial 2005; 18: 243-246.
17. Gaenzer H, Neumayr G, Marschang P et al. Flow-mediated vasodilation of the femoral and brachial artery induced by exercise in healthy nonsmoking and smoking men. J Am Coll Cardiol 2001; 38: 1313-1319.
18. Corpataux JM, Haesler E, Silacci P et al. Low-pressure environment and remodelling of the forearm vein in Brescia-Cimino haemodialysis access. Nephrol Dial Transplant 2002; 17: 1057-1062.
19. Girerd X, London G, Boutouyrie P et al. Remodeling of the radial artery in response to a chronic increase in shear stress. Hypertension 1996; 27: 799-803.
20. Dammers R, Tordoir JH, Kooman JP et al. The effect of flow changes on the arterial system proximal to an arteriovenous fistula for hemodialysis. Ultrasound Med Biol 2005; 31: 1327-1333.
21. Dobrin PB, Littooy FN, Golan J et al. Mechanical and histologic changes in canine vein grafts. J Surg Res 1988; 44: 259-265.
22. Kamiya A, Togawa T. Adaptive regulation of wall shear stress to flow change in the canine carotid artery. Am J Physiol 1980; 239: H14-21.
23. Ben Driss A, Benessiano J, Poitevin P et al. Arterial expansive remodeling induced by high flow rates. Am J Physiol 1997; 272: H851-H858.
24. Tohda K, Masuda H, Kawamura K et al. Difference in dilatation between endothelium-preserved and -desquamated segments in the flow-loaded rat common carotid artery. Arterioscler Thromb 1992; 12: 519-528.
25. Resnick N, Yahav H, Shay-Salit A et al. Fluid shear stress and the vascular endothelium: for better and for worse. Prog Biophys Mol Biol 2003; 81: 177-199.
26. Miller VM, Burnett Jr JC. Modulation of NO and endothelin by chronic increases in blood flow in canine femoral arteries. Am J Physiol 1992; 263: H103-H108.
27. Tronc F, Wassef M, Esposito B et al. Role of NO in flow-induced remodeling of the rabbit common carotid artery. Arterioscler Thromb Vasc Biol 1996; 16: 1256-1262.
28. Jones GT, Stehbens WE. The ultrastructure of arteries proximal to chronic experimental carotid-jugular fistulae in rabbits. Pathology 1995; 27: 36-42.
29. Greenhill NS, Stehbens WE. Scanning electron microscopic investigation of the afferent arteries of experimental femoral arteriovenous fistulae in rabbits. Pathology 1987; 19: 22-27.
30. Tronc F, Mallat Z, Lehoux S et al. Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO. Arterioscler Thromb Vasc Biol 2000; 20: E120-126.
31. Castier Y, Brandes RP, Leseche G et al. p47phox-dependent NADPH oxidase regulates flow-induced vascular remodeling. Circ Res 2005; 97: 533-540.
32. de Kleijn DP, Sluijter JP, Smit J et al. Furin and membrane type-1 metalloproteinase mRNA levels and activation of metalloproteinase-2 are associated with arterial remodeling. FEBS Lett 2001; 501: 37-41.
33. Sho E, Sho M, Singh TM et al. Arterial enlargement in response to high flow requires early expression of matrix metalloproteinases to degrade extracellular matrix. Exp Mol Pathol 2002; 73: 142-153.
34. Karwowski JK, Markezich A, Whitson J et al. Dose-dependent limitation of arterial enlargement by the matrix metalloproteinase inhibitor RS-113,456. J Surg Res 1999; 87: 122-129.
35. Magid R, Murphy TJ, Galis ZS. Expression of matrix metalloproteinase-9 in endothelial cells is differentially regulated by shear stress. Role of c-Myc. J Biol Chem 2003; 278: 32994-32999.
36. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002; 90: 251-262.
37. Pasterkamp G, Galis ZS, de Kleijn DP. Expansive arterial remodeling: location, location, location. Arterioscler Thromb Vasc Biol 2004; 24: 650-657.
38. Hollestelle SC, De Vries MR, Van Keulen JK et al. Toll-like receptor 4 is involved in outward arterial remodeling. Circulation 2004; 109: 393-398.
39. Wong V, Ward R, Taylor J et al. Factors associated with early failure of arteriovenous fistulae for haemodialysis access. Eur J Vasc Endovasc Surg 1996; 12: 207-213.
40. Yerdel MA, Kesenci M, Yazicioglu KM et al. Effect of haemodynamic variables on surgically created arteriovenous fistula flow. Nephrol Dial Transplant 1997; 12: 1684-1688.
41. Sivanesan S, How TV, Black RA et al. Flow patterns in the radiocephalic arteriovenous fistula: an in vitro study. J Biomech 1999; 32: 915-925.
42. Nath KA, Kanakiriya SK, Grande JP et al. Increased venous proinflammatory gene expression and intimal hyperplasia in an aorto-caval fistula model in the rat. Am J Pathol 2003; 162: 2079-2090.
43. Davies MG, Hagen PO. Pathophysiology of vein graft failure: a review. Eur J Vasc Endovasc Surg 1995; 9: 7-18.
44. Berceli SA, Jiang Z, Klingman NV et al. Early differential MMP-2 and -9 dynamics during flow-induced arterial and vein graft adaptations. J Surg Res 2006.
45. Southgate KM, Mehta D, Izzat MB et al. Increased secretion of basement membrane-degrading metalloproteinases in pig saphenous vein into carotid artery interposition grafts. Arterioscler Thromb Vasc Biol 1999; 19: 1640-1649.
46. Silva Jr MB, Hobson II RW, Pappas PJ et al. A strategy for increasing use of autogenous hemodialysis access procedures: impact of preoperative noninvasive evaluation. J Vasc Surg 1998; 27: 302-307; discussion 307-308.
47. Mendes RR, Farber MA, Marston WA et al. Prediction of wrist arteriovenous fistula maturation with preoperative vein mapping with ultrasonography. J Vasc Surg 2002; 36: 460-463.
48. Lockhart ME, Robbin ML, Allon M. Preoperative sonographic radial artery evaluation and correlation with subsequent radiocephalic fistula outcome. J Ultrasound Med 2004; 23: 161-168: quiz 169-171.
49. van der Linden J, Lameris TW, van den Meiracker AH et al. Forearm venous distensibility predicts successful arteriovenous fistula. Am J Kidney Dis 2006; 47: 1013-1019.
50. Malovrh M. Non-invasive evaluation of vessels by duplex sonography prior to construction of arteriovenous fistulas for haemodialysis. Nephrol Dial Transplant 1998; 13: 125-129.
51. Lin SL, Chen HS, Huang CH et al. Predicting the outcome of hemodialysis arteriovenous fistulae using duplex ultrasonography. J Formos Med Assoc 1997; 96: 864-868.
52. Robbin ML, Oser RF, Allon M et al. Hemodialysis access graft stenosis: US detection. Radiology 1998; 208: 655-661.
53. Miller CD, Robbin ML, Allon M. Gender differences in outcomes of arteriovenous fistulas in hemodialysis patients. Kidney Int 2003; 63: 346-352.
54. Prischl FC, Kirchgatterer A, Brandstatter E et al. Parameters of prognostic relevance to the patency of vascular access in hemodialysis patients. J Am Soc Nephrol 1995; 6: 1613-1618.
55. Caplin N, Sedlacek M, Teodorescu V et al. Venous access: women are equal. Am J Kidney Dis 2003; 41: 429-432.
56. Sivanesan S, How TV, Bakran A. Sites of stenosis in AV fistulae for haemodialysis access. Nephrol Dial Transplant 1999; 14: 118-120.
57. Tordoir JH, Rooyens P, Dammers R et al. Prospective evaluation of failure modes in autogenous radiocephalic wrist access for haemodialysis. Nephrol Dial Transplant 2003; 18: 378-383.
58. Turmel-Rodrigues L, Mouton A, Birmele B et al. Salvage of immature forearm fistulas for haemodialysis by interventional radiology. Nephrol Dial Transplant 2001; 16: 2365-2371.
59. Turmel-Rodrigues LA, Bourquelot P. Prospective evaluation of failure modes in autogenous radiocephalic access for haemodialysis: good diagnostic tools are necessary for effective multimodal treatments and autogenous elbow fistulas must not be ignored. Nephrol Dial Transplant 2003; 18: 2681; author reply 2681-2682.
60. Kim YO, Choi YJ, Kim JI et al. The impact of intima-media thickness of radial artery on early failure of radiocephalic arteriovenous fistula in hemodialysis patients. J Korean Med Sci 2006; 21: 284-289.
61. Shoji T, Nishizawa Y, Kawagishi T et al. Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis. Atherosclerosis 1997; 131: 229-236.
62. Safar ME, London GM, Plante GE. Arterial stiffness and kidney function. Hypertension 2004; 43: 163-168.
63. Mourad JJ, Girerd X, Boutouyrie P et al. Increased stiffness of radial artery wall material in end-stage renal disease. Hypertension 1997; 30: 1425-1430.
64. Covic A, Gusbeth-Tatomir P, Goldsmith DJ. Arterial stiffness in renal patients: an update. Am J Kidney Dis 2005; 45: 965-977.
65. Ejerblad S, Ericsson JL, Eriksson I. Arterial lesions of the radial artery in uraemic patients. Acta Chir Scand 1979; 145: 415-428.
66. Ibels LS, Stewart JH, Mahony JF et al. Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients. A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of arteriosclerosis. Q J Med 1977; 46: 197-214.
67. Wali MA, Eid RA, Dewan M et al. Intimal changes in the cephalic vein of renal failure patients before arterio-venous fistula (AVF) construction. J Smooth Muscle Res 2003; 39: 95-105.
68. Wali MA, Eid RA, Al-Homrany MA. Smooth muscle changes in the cephalic vein of renal failure patients before use as an arteriovenous fistula (AVF). J Smooth Muscle Res 2002; 38: 75-85.
69. London GM, Marchais SJ, Guerin AP et al. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr Opin Nephrol Hypertens 2005; 14: 525-531.
70. Amann K, Wolf B, Nichols C et al. Aortic changes in experimental renal failure: hyperplasia or hypertrophy of smooth muscle cells? Hypertension 1997; 29: 770-775.
71. Amann K, Neususs R, Ritz E et al. Changes of vascular architecture independent of blood pressure in experimental uremia. Am J Hypertens 1995; 8: 409-417.
72. Chowdhury UK, Airan B, Mishra PK et al. Histopathology and morphometry of radial artery conduits: basic study and clinical application. Ann Thorac Surg 2004; 78: 1614-1621.
73. Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 2004; 95: 560-567.
74. Himmelfarb J. Relevance of oxidative pathways in the pathophysiology of chronic kidney disease. Cardiol Clin 2005; 23: 319-330.
75. Nanayakkara PW, Teerlink T, Stehouwer CD et al. Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure. Kidney Int 2005; 68: 2230-2236.
76. Fliser D. Asymmetric dimethylarginine (ADMA): the silent transition from an 'uraemic toxin' to a global cardiovascular risk molecule. Eur J Clin Invest 2005; 35: 71-79.
77. Amann K, Gross ML, Ritz E. Pathophysiology underlying accelerated atherogenesis in renal disease: closing in on the target. J Am Soc Nephrol 2004; 15: 1664-1666.
78. Cross JM, Donald A, Vallance PJ et al. Dialysis improves endothelial function in humans. Nephrol Dial Transplant 2001; 16: 1823-1829.
79. Hand MF, Haynes WG, Webb DJ. Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction. Kidney Int 1998; 53: 1068-1077.
80. Cross JM, Donald AE, Kharbanda R et al. Acute administration of L-arginine does not improve arterial endothelial function in chronic renal failure. Kidney Int 2001; 60: 2318-2323.
81. Paszkowiak JJ, Dardik A. Arterial wall shear stress: observations from the bench to the bedside. Vasc Endovasc Surg 2003; 37: 47-57.
82. Van Tricht I, De Wachter D, Tordoir J et al. Hemodynamics and complications encountered with arteriovenous fistulas and grafts as vascular access for hemodialysis: a review. Ann Biomed Eng 2005; 33: 1142-1157.
83. Schillinger F, Schillinger D, Montagnac R et al. Post catheterisation vein stenosis in haemodialysis: comparative angiographic study of 50 subclavian and 50 internal jugular accesses. Nephrol Dial Transplant 1991; 6: 722-724.
84. Nugent HM, Groothuis A, Seifert P et al. Perivascular endothelial implants inhibit intimal hyperplasia in a model of arteriovenous fistulae: a safety and efficacy study in the pig. J Vasc Res 2002; 39: 524-533.
85. Werner N, Junk S, Laufs U et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 2003; 93: e17-e24.
86. Kong D, Melo LG, Gnecchi M et al. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 2004; 110: 2039-2046.
87. Rotmans JI, Heyligers JM, Verhagen HJ et al. In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation 2005; 112: 12-18.
88. Lassila M, Allen TJ, Cao Z et al. Imatinib attenuates diabetes-associated atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24: 935-942.
89. Takeda R, Suzuki E, Satonaka H et al. Blockade of endogenous cytokines mitigates neointimal formation in obese Zucker rats. Circulation 2005; 111: 1398-1406.
90. Dixon BS, Beck GJ, Dember LM et al. Design of the dialysis access consortium (DAC) aggrenox prevention of access stenosis. Trial Clin 2005; 2: 400-412.
91. Rotmans JI, Pattynama PM, Verhagen HJ et al. Sirolimus-eluting stents to abolish intimal hyperplasia and improve flow in porcine arteriovenous grafts: a 4-week follow-up study. Circulation 2005; 111: 1537-1542.
92. Masaki T, Rathi R, Zentner G et al. Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel. Kidney Int 2004; 66: 2061-2069.
93. Chandiwal A, Balasubramanian V, Baldwin ZK et al. Gene therapy for the extension of vein graft patency: a review. Vasc Endovasc Surg 2005; 39: 1-14.
94. Luo Z, Akita GY, Date T et al. Adenovirus-mediated expression of beta-adrenergic receptor kinase C-terminus reduces intimal hyperplasia and luminal stenosis of arteriovenous polytetrafluoroethylene grafts in pigs. Circulation 2005; 111: 1679-1684.
95. Rotmans JI, Verhagen HJ, Velema E et al. Local overexpression of C-type natriuretic peptide ameliorates vascular adaptation of porcine hemodialysis grafts. Kidney Int 2004; 65: 1897-1905.
96. Alexander JH, Hafley G, Harrington RA et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA 2005; 294: 2446-2454.
97. Amabile PG, Wong H, Uy M et al. In vivo vascular engineering of vein grafts: directed migration of smooth muscle cells by perivascular release of elastase limits neointimal proliferation. J Vasc Interv Radiol 2002; 13: 709-715.
98. Wong AH, Waugh JM, Amabile PG et al. In vivo vascular engineering: directed migration of smooth muscle cells to limit neointima. Tissue Eng 2002; 8: 189-199.
99. Wanner C, Krane V, Marz W et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248.
100. Stenvinkel P, Lindholm B, Heimburger O. Novel approaches in an integrated therapy of inflammatory-associated wasting in end-stage renal disease. Semin Dial 2004; 17: 505-515.
101. Kass DA, Shapiro EP, Kawaguchi M et al. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 2001; 104: 1464-1470.
102. Davies MR, Lund RJ, Hruska KA. BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure. J Am Soc Nephrol 2003; 14: 1559-1567.
103. Moe SM, Reslerova M, Ketteler M et al. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 2005; 67: 2295-2304.